Aristeia Capital’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$498K Buy
10,529
+1,905
+22% +$97.9K 0.01% 424
2026
Q1
$511K Buy
8,624
+1,232
+17% +$79.9K 0.01% 365
2025
Q4
$456K Buy
+7,392
New +$452K 0.01% 339
2025
Q3
Sell
-4,737
Closed -$378K 603
2025
Q2
$378K Sell
4,737
-60
-1% -$5.02K 0.01% 253
2025
Q1
$412K Buy
+4,797
New +$393K 0.01% 205
2024
Q4
Sell
-7,891
Closed -$569K 429
2024
Q3
$569K Buy
+7,891
New +$559K 0.01% 163

Other funds holding PBH

Aristeia Capital's PBH Position: Q2 2026 in Review

Aristeia Capital increased its Prestige Consumer Healthcare (PBH) stake by 22% in Q2 2026, buying an estimated $97.9K and bringing the position to 10,529 shares worth $498K. The position accounts for 0.01% of the portfolio, ranked #424.

Aristeia Capital first reported a position in PBH in Q3 2024 and has held it in 6 quarters since. The position peaked at $569K in Q3 2024. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Aristeia Capital held 10,529 shares of Prestige Consumer Healthcare worth $498K as of Q2 2026.
  • Aristeia Capital bought 1,905 Prestige Consumer Healthcare shares in Q2 2026, an estimated $97.9K.
  • Prestige Consumer Healthcare made up 0.01% of Aristeia Capital's portfolio in Q2 2026, its #424 holding.
  • Aristeia Capital first reported a position in Prestige Consumer Healthcare in Q3 2024 and has held it in 6 quarters since.
  • Aristeia Capital's Prestige Consumer Healthcare position peaked at $569K in Q3 2024.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Aristeia Capital's 13F filing for Q2 2026, filed 14 Aug 2026.